No photo of John Lubel

View Scopus Profile

John Lubel

Adj Assoc Prof

20052020

Research output per year

If you made any changes in Pure these will be visible here soon.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

Hepatology Clinical Trials

Lubel, J.

1/01/15 → 30/12/20

Project: Research

Community Approach Targeting Cirrhosis and Hepatocellular carcinoma (CATCH) in patients living with chronic viral hepatitis

Lubel, J.

17/04/17 → 16/04/19

Project: Research

NHMRC Equipment Grant - BD FGACSAria Fusion Cell Sorter

Davis, I., Dear, A., Gilfillan, C., Lubel, J. & McMahon, L.

National Health & Medical Research Council (NHMRC)

5/12/14 → 31/12/15

Project: Research

A randomised, double-blind, placebo-controlled multi centre phase III study of regorafenib in patients with hepatocellular carcinoma (HCC) after sorafenib

Lubel, J.

31/05/13 → 23/10/14

Project: Research

The Renin Angiotensin System in Inflammatory Bowel Disease

Lubel, J., Angus, P., Burrell, L., Garg, M. & Gibson, P.

The Broad Foundations

1/03/13 → 31/03/16

Project: Research

Research Output

Survival of patients with ruptured and non-ruptured hepatocellular carcinoma

Tan, N. P., Majeed, A., Roberts, S. K., Gow, P. J., Hey, P., Mah, X., Goodwin, M., Sood, S., Lubel, J., Nicoll, A., Dev, A., Bell, S. J. & Kemp, W. W., 25 Jan 2020, (Accepted/In press) In : Medical Journal of Australia. 2 p.

Research output: Contribution to journal › Letter › Other › peer-review

Imbalance of the renin-angiotensin system may contribute to inflammation and fibrosis in IBD: Novel therapeutic target?

Garg, M., Royce, S. G., Tikellis, C., Shallue, C., Batu, D., Velkoska, E., Burrell, L. M., Patel, S. K., Beswick, L., Jackson, A., Britto, K., Lukies, M., Sluka, P., Wardan, H., Hirokawa, Y., Tan, C. W., Faux, M., Burgess, A. W., Hosking, P., Monagle, S. & 3 others, Thomas, M., Gibson, P. R. & Lubel, J., 13 Aug 2019, (Accepted/In press) In : Gut. 11 p.

Research output: Contribution to journal › Article › Research › peer-review

Real-world Australian data reflect very high sustained virologic response at 12 weeks with direct acting antiviral therapy for hepatitis C and suggests highly achievable even in those without an end-of-treatment response

Williams, J., Lucarelli, N., Nicoll, A. & Lubel, J., May 2019, In : Internal Medicine Journal. 49, 5, p. 666-669 4 p.

Research output: Contribution to journal › Article › Research › peer-review

Sustained virologic response to direct-acting antiviral therapy in patients with chronic hepatitis C and hepatocellular carcinoma: A systematic review and meta-analysis

Ji, F., Yeo, Y. H., Wei, M. T., Ogawa, E., Enomoto, M., Lee, D. H., Iio, E., Lubel, J., Wang, W., Wei, B., Ide, T., Preda, C. M., Conti, F., Minami, T., Bielen, R., Sezaki, H., Barone, M., Kolly, P., Chu, P. S., Virlogeux, V. & 15 others, Eurich, D., Henry, L., Bass, M. B., Kanai, T., Dang, S., Li, Z., Dufour, J. F., Zoulim, F., Andreone, P., Cheung, R. C., Tanaka, Y., Furusyo, N., Toyoda, H., Tamori, A. & Nguyen, M. H., 13 May 2019, (Accepted/In press) In : Journal of Hepatology. 13 p.

Research output: Contribution to journal › Article › Research › peer-review

6 Citations (Scopus)

The intestinal vitamin D receptor in inflammatory bowel disease: inverse correlation with inflammation but no relationship with circulating vitamin D status

Garg, M., Royce, S. G., Tikellis, C., Shallue, C., Sluka, P., Wardan, H., Hosking, P., Monagle, S., Thomas, M., Lubel, J. S. & Gibson, P. R., 1 Jan 2019, In : Therapeutic Advances in Gastroenterology. 12, p. 1-15 15 p.

Research output: Contribution to journal › Article › Research › peer-review

Open Access
File
5 Citations (Scopus)